Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2012
05/09/2012CN101703470B Solid preparation of fluconazole liposome and new application thereof
05/09/2012CN101654686B Multi-target-spot siRNA recombinant slow virus carrier for acquired immune deficiency syndrome gene therapy
05/09/2012CN101633909B Attenuated live vaccine strain for preventing pig-pig infection breeding and respiratory syndrome
05/09/2012CN101559096B Verruca-eliminating liquid medicine and preparation method thereof
05/09/2012CN101554476B Aftosa vaccine immunopotentiator
05/09/2012CN101549155B Porcine circovirus type II inactivated vaccine and method for preparing same
05/09/2012CN101531691B Triazole glucoside, method for synthesizing same by enzyme chemical method and application thereof
05/09/2012CN101530466B Nano medicament containing oregano oil and vitamins
05/09/2012CN101530434B Method for preparing silkworm powder, pupa powder or pupa serum powder containing antibacterial peptide
05/09/2012CN101514229B Human interferon alpha derivative and polyethylene glycol modified substance thereof
05/09/2012CN101508717B Synthesis of tuberculosis resistant compound of arguesterol
05/09/2012CN101486651B Method for extracting chlorogenic acid from Eucommia leaves and use thereof
05/09/2012CN101474168B Fenticonazole nitrate vaginal soft capsule and preparation method thereof
05/09/2012CN101473832B Novel environment-friendly type disinfecting liquid
05/09/2012CN101444568B Method for preparing Sophora alopecuroides skin bacteriostasis spray
05/09/2012CN101380323B Pharmaceutical composition and use thereof
05/09/2012CN101371832B Medical use of triacetyl andrographolide as proinflammatory cytokine inhibitor
05/09/2012CN101343319B Anti-dengue virus E protein monoclone antibody, preparation method and uses thereof
05/09/2012CN101332229B Prunella plant extract and pharmaceutical use thereof
05/09/2012CN101317843B Amoxicillin sulbactam pivoxil oral preparation and preparation method thereof
05/09/2012CN101274953B Method for extracting corosolic acid from plant
05/09/2012CN101260148B Hybrid and tandem expression of neisserial proteins
05/09/2012CN101194953B Externally used traditional Chinese medicine composition for treating tinea unguium
05/09/2012CN101190231B Bykomycin chewable tablets for dog or cat
05/09/2012CN101119734B RNAI modulation of RSV and therapeutic uses thereof
05/09/2012CN101016270B Substituted piperazinphenylisoxazoline derivative and use thereof
05/09/2012CN101014620B Antibodies against clostridium difficile toxins and uses thereof
05/08/2012US8173798 Vaccine
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173767 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
05/08/2012US8173663 Dipeptidyl peptidase inhibitors
05/08/2012US8173662 Fused pyrimidines as inhibitors of nucleoside phosphorylases and nucleosidases
05/08/2012US8173646 FAB I inhibitors
05/08/2012US8173606 Sulfated oligosaccharide derivatives
05/08/2012US8173141 Immunogenic complexes and methods relating thereto
05/08/2012US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm
05/08/2012US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2492153C Production of polyketide fkbp-ligand analogues
05/08/2012CA2469334C Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/08/2012CA2459224C 1,3-benzothiazinone derivatives and the use thereof
05/08/2012CA2421447C Collections of repeat proteins comprising repeat modules
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/08/2012CA2266859C Colostrinin, and uses thereof
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012WO2012058526A1 Inhibition of microbial growth by aconitase inhibition
05/03/2012WO2012058493A2 Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
05/03/2012WO2012058492A2 Viral vaccine and process for preparing the same
05/03/2012WO2012058363A2 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
05/03/2012WO2012057894A1 Econazole composition and methods of treatment therewith
05/03/2012WO2012057713A1 Antimicrobial peptides
05/03/2012WO2012057599A1 Anti-mycobacterial agents
05/03/2012WO2012057575A2 Feed additive composition containing turmeric extracts and stevia extracts as active ingredients for increasing resistance to white spot syndrome viruses, and feed composition comprising same
05/03/2012WO2012057525A2 Liquid formulations of long acting interferon alpha conjugate
05/03/2012WO2012056387A2 A dermaceutical gel made using sodium fusidate and a process to make it
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012055980A1 Antibodies for the treatment of hiv
05/03/2012WO2012055846A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)-1-pi perazinyl] methyl} -1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/03/2012WO2012055362A1 Hbv treatment
05/03/2012WO2012055205A1 Pegylated recombinant consensus interferon variant conjugate and preparation mehtod and uses thereof
05/03/2012WO2012055034A1 Sulfonamides as hiv protease inhibitors
05/03/2012WO2012055031A1 Hiv protease inhibitors
05/03/2012WO2012055030A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012WO2012054999A1 Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof
05/03/2012WO2012025831A3 Salmonella vaccine proteins
05/03/2012WO2012006437A3 Polypeptides having antiviral activity and methods for use thereof
05/03/2012WO2011159137A3 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient
05/03/2012WO2011150320A3 Activators of innate immunity
05/03/2012WO2011145885A3 Composition for screening and a screening method for substances active in treating hepatitis b
05/03/2012US20120108823 Anti-francisella agents
05/03/2012US20120108649 Methods and compositions to protect aquatic invertebrates from disease
05/03/2012US20120108620 Forms of rifaximin and uses thereof
05/03/2012US20120108618 Thia-triaza-indacenes
05/03/2012US20120108615 Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification
05/03/2012US20120108603 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
05/03/2012US20120108601 Crystalline pyridazine compound
05/03/2012US20120108592 Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses
05/03/2012US20120108591 Alkylsulfinyl-substituted thiazolide compounds
05/03/2012US20120108588 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) carbaldehyde derivatives
05/03/2012US20120108583 Tricyclic Compounds As mPGES-1 Inhibitors
05/03/2012US20120108582 Fused substituted aminopyrrolidine derivative
05/03/2012US20120108577 Compounds for the treatment of multi-drug resistant bacterial infections
05/03/2012US20120108569 8-AZA Tetracycline Compounds
05/03/2012US20120108565 Pyrrole carboxylic acid derivatives as antibacterial agents
05/03/2012US20120108564 1,3,4,8-Tetrahydro-2H-Pyrido[1,2-a]Pyradine Derivatives and Use Thereof as HIV Integrase Inhibitor
05/03/2012US20120108557 Fluoroquinolone derivatives for ophthalmic applications
05/03/2012US20120108545 Trioxane Monomers and Dimers
05/03/2012US20120108533 Novel phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
05/03/2012US20120108531 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
05/03/2012US20120108530 Enhanced Neoglycosides Through Neoglycosylation and Methods of Use Thereof
05/03/2012US20120108529 Protease inhibitors
05/03/2012US20120108527 Polymeric topical compositions
05/03/2012US20120108520 Antimicrobial Compounds and Formulations
05/03/2012US20120108509 Artificial scab for use in an airway
05/03/2012US20120108501 Protease Inhibitors
05/03/2012US20120108500 Compositions and Methods for Modulating Immunodeficiency Virus Transcription
05/03/2012US20120108499 Peptoid compounds
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 1798